MarketPlace Logan, an affiliate of Boston-based New England Development and manager of the Boston Logan Concessions’ program (BOS SHOP DINE), announced Thursday that XpresSpa Group’s new XpresCheck COVID-19 testing facility will open and be fully operational by mid-November at Boston Logan International Airport.
The XpresCheck COVID-19 testing facility at Boston Logan is a modular constructed facility within the International Arrival area in Terminal E (pre-security), and is expected to host seven separate testing rooms with an anticipated ability to administer over 400 tests per day for passengers arriving and departing the airport within all terminals, as well as airport employees. There are three COVID-19 testing options offered, including a rapid molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test, and the Blood Antibody Test.
Airport employees and travelers alike can visit the XpresCheck via walk-in appointments or by scheduling in advance. Pricing varies ($75 for an individual PCR Test or individual Blood Antibody Test, $90 for both, $200 for the rapid molecular COVID-19 test, or $215 for the rapid molecular COVID-19 test plus additional tests offered. XpresCheck also accepts insurance for the individual PCR and Blood Antibody Test. The entire testing process, which involves introductions, administering the test and the clinical visit, takes up to approximately 20 minutes and results are provided onsite if having the rapid molecular COVID-19 test or shared via XpresCheck’s secure patient portal.
Travelers looking to make an appointment in advance for a more contactless experience can log onto XpresCheck’s website at www.xprescheck.com. Once open in November, XpresCheck will be open Monday through Friday from 10 a.m. – 6p.m.
Related Stories
In-Flight COVID-19 Transmission Incidence Is Low, IATA Finds
American Airlines Boosting Flights to the U.S. Virgin Islands
Emirates Launches New NDC-Powered Gateway for Trade Partners